Price
Target price
-
-
-
-
-
-
WKN: A1XEAC / Symbol: CNCE / Name: Concert Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Concert Pharmaceuticals Inc. Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Concert Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Concert Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Concert Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Concert Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Evolus Inc | 0.680% | 8.824% | 23.333% | 70.115% | 63.536% | 120.896% | - |
Ardelyx Inc. | -3.940% | 7.242% | 4.451% | 29.696% | -4.187% | 390.088% | 30.598% |
Coherus Bioscien. | 1.760% | -24.782% | -18.208% | -79.734% | -69.368% | -93.792% | -95.284% |
Comments
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CNCE provided by MarketBeat